270. Chronic recurrent multifocal osteomyelitis Disease details / Clinical trials / Drug dev / DR info


Clinical trial : 1 Drugs : 11 - (DrugBank : 9) / Drug target genes : 6 - Drug target pathways : 71

Drugs, Primary sponsors and Trial info (Enrollment year, Phase, Trial ID, Countries)
Adalimumab
   Seattle Children's Hospital
      2018   -   NCT04725422   United States
Certolizumab
   Seattle Children's Hospital
      2018   -   NCT04725422   United States
Etanercept
   Seattle Children's Hospital
      2018   -   NCT04725422   United States
Golimumab
   Seattle Children's Hospital
      2018   -   NCT04725422   United States
Infliximab
   Seattle Children's Hospital
      2018   -   NCT04725422   United States
Leflunomide
   Seattle Children's Hospital
      2018   -   NCT04725422   United States
Methotrexate
   Seattle Children's Hospital
      2018   -   NCT04725422   United States
Nsaid
   Seattle Children's Hospital
      2018   -   NCT04725422   United States
Pamidronate
   Seattle Children's Hospital
      2018   -   NCT04725422   United States
Sulfasalazine
   Seattle Children's Hospital
      2018   -   NCT04725422   United States
Zoledronic acid
   Seattle Children's Hospital
      2018   -   NCT04725422   United States